Back to search

Article

Predictive value of<i>SLCO1B1</i>c.521T>C polymorphism on observed changes in the treatment of 1136 statin-users

2022-08-30

Abstract excerpt

<h4>Purpose</h4> Pharmacogenomic testing is a method to prevent adverse drug reactions. Pharmacogenomics could be relevant to optimize statin treatment, by identifying patients at high risk for adverse drug reactions. We aim to investigate the clinical validity and utility of pre-emptive pharmacogenomics screening in primary care, with SLCO1B1 c.521T>C as a risk factor for statin induced adverse drug reactions. <h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
64af2440-56bd-5022-8e52-bf64e694bf0b
DOI
10.1101/2022.08.29.22279331
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predictive value of<i>SLCO1B1</i>c.521T>C polymorphism on observed changes in the treatment of 1136 statin-usersDOI 10.1101/2022.08.29.22279331
Select a neighboring publication to make it the new centre.